Clinical trial
The K-Map Study, Global Prevalence of KC
NCT03115710 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The K-Map Study, Global Prevalence of KC
- Lead sponsor
- University Hospital, Geneva
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 28, 2015
- Completion date
- February 1, 2030
- Enrollment
- 20,000 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.